Abstract

Background Changes in BUN have been proposed as a risk factor for complications in acute pancreatitis (AP). Our study aimed to compare changes in BUN versus the Bedside Index for Severity in Acute Pancreatitis (BISAP) score and the Acute Physiology and Chronic Health Evaluation-II score (APACHE-II), as well as other laboratory tests such as haematocrit and its variations over 24 h and C-reactive protein, in order to determine the most accurate test for predicting mortality and severity outcomes in AP. Methods Clinical data of 410 AP patients, prospectively enrolled for study at our institution, were analyzed. We define AP according to Atlanta classification (AC) 2012. The laboratory test's predictive accuracy was measured using area-under-the-curve receiver-operating characteristics (AUC) analysis and sensitivity and specificity tests. Results Rise in BUN was the only score related to mortality on the multivariate analysis (p=0.000, OR: 12.7; CI 95%: 4.2−16.6). On the comparative analysis of AUC, the rise in BUN was an accurate test in predicting mortality (AUC: 0.842) and persisting multiorgan failure (AUC: 0.828), similar to the BISAP score (AUC: 0.836 and 0.850) and APACHE-II (AUC: 0.756 and 0.741). The BISAP score outperformed both APACHE-II and rise in BUN at 24 hours in predicting severe AP (AUC: 0.873 vs. 0.761 and 0.756, respectively). Conclusion Rise in BUN at 24 hours is a quick and reliable test in predicting mortality and persisting multiorgan failure in AP patients.

Highlights

  • Severe acute pancreatitis (SAP) occurs in nearly 20% of acute pancreatitis (AP) patients, and it is related to higher mortality rates around 30% [1, 2]. e mortality is significantly higher in patients with necrotizing pancreatitis (NP) due to the incidence of systemic and local complications, including infection of the pancreatic necrosis in 20% of patients [2,3,4], and recently, our group has demonstrated that extrapancreatic infection played a role in predicting the severity and local complications in AP [5]

  • Canadian Journal of Gastroenterology and Hepatology e rise in blood urea nitrogen (BUN) in AP patients are explained by a mechanism of acute renal injury consequence of (a) the loss of intravascular volume, due to interstitial extravasations related to the systemic inflammatory response (SIRS) [9, 12, 16] and (b) a direct renal injury mechanism, occurring in AP promoted by the releasing of activated enzymes such trypsin and chymotrypsin, inflammatory mediators, and cytokines (TNF-alpha, IL-8, IL-6, and IL-1 beta) [17]

  • Our study aimed to explore the role of BUN changes, compared with APACHE-II, haemoconcentration, and C-reactive protein (CRP), in predicting mortality and severity in patients diagnosed with acute pancreatitis

Read more

Summary

Introduction

Severe acute pancreatitis (SAP) occurs in nearly 20% of acute pancreatitis (AP) patients, and it is related to higher mortality rates around 30% [1, 2]. e mortality is significantly higher in patients with necrotizing pancreatitis (NP) due to the incidence of systemic and local complications, including infection of the pancreatic necrosis in 20% of patients [2,3,4], and recently, our group has demonstrated that extrapancreatic infection played a role in predicting the severity and local complications in AP [5].Mortality and severity prediction of AP remains to be a challenge. Few studies have compared it with one of the essential clinical scores such as BISAP and APACHE-II, with contradictory results [7, 9, 12,13,14,15]. Our study aimed to compare changes in BUN versus the Bedside Index for Severity in Acute Pancreatitis (BISAP) score and the Acute Physiology and Chronic Health Evaluation-II score (APACHE-II), as well as other laboratory tests such as haematocrit and its variations over 24 h and C-reactive protein, in order to determine the most accurate test for predicting mortality and severity outcomes in AP. On the comparative analysis of AUC, the rise in BUN was an accurate test in predicting mortality (AUC: 0.842) and persisting multiorgan failure (AUC: 0.828), similar to the BISAP score (AUC: 0.836 and 0.850) and APACHE-II (AUC: 0.756 and 0.741). Rise in BUN at 24 hours is a quick and reliable test in predicting mortality and persisting multiorgan failure in AP patients

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call